Beta Bionics, Inc. (BBNX)
NGM – Real vaqt narxi. Valyuta: USD
16.82
+0.91 (5.72%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
16.82
-0.00 (-0.00%)
Bozordan keyin: Jun 26, 2026, 4:31 PM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
16.82
+0.91 (5.72%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
16.82
-0.00 (-0.00%)
Bozordan keyin: Jun 26, 2026, 4:31 PM EDT
Beta Bicks, Inc., tijorat bosqichidagi tibbiy asboblar kompaniyasi, insulin talab qiladigan diabetga chalinganlar uchun hayot sifatini va salomatligini yaxshilashga qaratilgan yechimlarni ishlab chiqish, rivojlantirish va tijoratlashtirish bilan shug'ullanadi. U kattalar va olti yosh va undan katta bolalarda 1-toifa diabetni davolash uchun insulin yetkazib beruvchi qurilma bo'lgan iLet Bionic Pancreas'ni taklif etadi. Kompaniya, shuningdek, Patch Pumpni ishlab chiqmoqda, bu insulin nasosidir, u to'g'ridan-to'g'ri teriga yopishish uchun mo'ljallangan va naychalarsiz insulin yuboradi; Bihormonal iLet, bu insulin va glyukagonning avtomatlashtirilgan yetkazib berishni birlashtiradi; va iLet insulin-bog'liq 2-toifa diabet bilan og'rigan bemorlarni davolash uchun. Kompaniya Xeris Pharmaceuticals, Inc. (Xeris) bilan nasosga mos keladigan glyukagon formulatsiyasini ishlab chiqish va tijoratlashtirish uchun hamkorlik va litsenziyalash shartnomasiga ega; va Abbott Diabetes Care Inc. bilan avtomatlashtirilgan insulin yetkazib berish tizimini ishlab chiqish va tijoratlashtirish bo'yicha rivojlanish va tijoratlashtirish shartnomasiga ega. Kompaniya 2015 yilda tashkil etilgan va shtab-kvartirasi Irvayn, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Blake Beber | Head of Investor Relations |
| Dr. Steven Russell M.D., Ph.D. | Chief Medical Officer |
| Mr. David Henderson | Vice President of Operations |
| Mr. Mark Hopman M.B.A., R.Ph. | Chief Commercial Officer |
| Mr. Mike Mensinger | Chief Product Officer |
| Mr. Sean T. Saint PE | President, CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-22 | 8-K | f8k_052226.htm |
| 2026-05-21 | 8-K | f8k_052126.htm |
| 2026-04-21 | 8-K | f8k_042126.htm |
| 2026-04-21 | 10-Q | bbnx-20260331.htm |
| 2026-04-10 | DEFA14A | bbnx_defa_14a_naa_2026.htm |
| 2026-04-10 | DEF 14A | bbnx-20260408.htm |
| 2026-02-24 | S-8 | d795774ds8.htm |
| 2026-02-24 | S-3ASR | d90218ds3asr.htm |
| 2026-02-24 | 10-K | bbnx-20251231.htm |
| 2026-02-17 | 8-K | f8k_021326.htm |
| Mr. Stephen H. Feider | CFO, Treasurer & Secretary |